Superior MTA1-mediated anticancer effects of Gnetin C also included a downregulation of oncogenic/tumor-promoting ETS2, pAkt/Akt, Cyclin D1, p-mTOR/pS6K/p4EBP1 and AR signaling [44,51,52,53,54] (Table 2). The gene discussed is AKT1; the disease is neoplasm.